[PDF] Top 20 Development of leukemia in donor cells after allogeneic stem cell transplantation a survey of the European Group for Blood and Marrow Transplantation (EBMT)

... Bone Marrow Transplantation, University Hospital, Essen, Germany (CIC 259) (AE); BMT Center, Deutsche Klinik für Diagnostik, Wiesbaden, Germany (CIC 311) (RS); ... See full document

... of transplantation, age, gender, status at transplantation, time to diagnosis to complete re- mission, time to complete remission to allo-SCT, number of induction courses, type of conditioning regimen, in ... See full document

... allo-HSCT: Allogeneic hematopoietic stem cell transplantation; AP: Accelerated phase; ASBMT: American Society for Blood and Marrow Transplantation; ATG: Anti-thymocyte ... See full document

... acute leukemia working party (ALWP) of the EBMT group ...working group of more than 500 transplant centers that are required to report all consecutive stem cell transplantations ... See full document

... FT group in- cluded significantly older patients compared to the TBF and FLAMSA cohorts (median age 58, 52, and 52 years, respectively, p < 10 − 3 ...of donor and patient differed between the three ... See full document

... Under normal physiological conditions, γδTregs exist at very low frequencies in PB, and they are decreased in PB in some autoimmune diseases [12, 15]. Li et al. [12] reported that γδTregs could be induced from PBMCs in  ... See full document

... When a corticotropin deficiency has been confirmed by laboratory test results, it is advisable to replace synthetic corticosteroids by 20 mg/day of natural hydrocortisone, if the intention was to stop synthetic ... See full document

... need after allo-HSCT in B cell ...CAR-T cells without serious complications after allo-HSCT; however, the outcome requires further im- ...of cell therapies is related to the low tumor ... See full document

... autologous stem cell transplantation; AWD, alive with disease; CR, complete remission; CHOP, cyclophosphamide, doxoru- bicin, vincristine, and prednisone; DLBCL, diffuse large B-cell lymphoma; ... See full document

... peripheral blood stem- cell and autologous bone marrow transplantation for lymphoma patients: A case- controlled analysis of the EBMT Registry ... See full document

... year after transplant. It was sug- gested that CD34 + donor cells consistently modified their methylation pattern during the engraftment phase, which occurs 2 to 4 weeks after ...endothelial ... See full document

... immediately after the diagnosis of MDS of high- and higher-risk ...bone marrow with ≤ 5% myeloblasts with nor- mal maturation of all cell lines, hemoglobin ≥ 11 g/dL, platelets ≥ 100×10 9 /L, ... See full document

... bone marrow involvement was presented in this patient at diagnosis, which indicated that the patient was seriously ill and the disease was highly aggressive with a high rate of ... See full document

... SCT: Stem Cell Transplantation; Allo-SCT: Allogeneic Stem Cell Transplantation; BMT: Bone Marrow Transplant; PS: Propensity Score; IPW: Inverse Probability of ... See full document

... hematopoietic stem cells may “reset” the immune reconstitution and induce the self-tolerance of autoreactive T and B ...SSc after autologous ...of allogeneic HSCT in SSc patients, but ... See full document

... Mit einem Anteil von 88% war das periphere Blut des Spenders der Haupt- Entnahmeort der im Verlauf transplantierten Stammzellen. Es ergaben sich signi- fikant bessere Überlebenszeiten gegenüber der Verwendung von ... See full document

... AUC after the first dose was 5113 μ M*min (range 2796 - 9355) for the 5300 μ M*min tar- get subgroup and 4244 uM*min (range 2830 - 5347) for the 3500 μM*min target ...μM/L*min group and 418 mg/m 2 (range ... See full document

... second allogeneic hematopoietic stem cell transplantation (HSCT) for relapse after initial allogeneic transplant in childhood leukemia, we reviewed twenty-one patients who ... See full document

... community after allogeneic hematopoietic stem cell transplantation ...the donor is CMV-seronegative [1, ...the survey of Pollack et ...use after allogen- eic HSCT, ... See full document

... using cells that were transduced with lentiviral vectors expressing ...gene-modified cells were reinfused after a conditioning regimen consisting of anti-CD20 mono- clonal antibody, busulfan, and ... See full document